MedCity News August 15, 2022
Many have celebrated the historic strides in healthcare made with the House passage Friday of the Inflation Reduction Act. While there is widespread praise for the eventual start of Medicare negotiating drug prices, not all believe it will make a huge difference on the drug industry. The Act left out individuals who are covered by private insurance, and left pharmacy benefit managers, who negotiate drug prices, off the hook
The Inflation Reduction Act includes a provision that Medicare will begin negotiating drug prices in 2026, a top desire by some lawmakers who for years have tried to have more government intervention in the drug pricing industry. The Congressional Budget Office has estimated that the provisions would save the Center for...
Today's Sponsors
Today's Sponsor